BioCentury
ARTICLE | Clinical News

Dara BioSciences preclinical data

November 16, 2009 8:00 AM UTC

In mouse models of diabetes, DB959 significantly lowered blood glucose levels and improved glucose tolerance compared with baseline. The company expects to begin Phase I testing of the dual peroxisom...